Martindale Pharma is pleased to announce that the Company has joined the Sunday Times Deloitte Buyout Track 100, as one of the top 100 fastest growing private equity backed companies in 2012
News Archives
Martindale Pharma is pleased to announce the launch today of Latanoprost 0.005% w/v eye drop solution (2.5ml solution), a first in line treatment for Glaucoma
Martindale Pharma® is pleased to announce that it has launched Methylthioninium chloride Proveblue® for the treatment of medicinal and chemical products.
Martindale Pharma® is pleased to announce that it has introduced a number of significant improvements to its market-leading Aurum Range of eleven pre-filled syringes.
Martindale Pharma® announces its ophthalmic range of products will start appearing in brand new eye-catching, colour-coded and easy-to-read packaging.
Martindale Pharma® today announces the launch of their new corporate website
Martindale Pharma today announces the introduction of a new 2.5 litre plastic bottle for Physeptone oral solution.
Martindale Pharma today announces the introduction of new packaging for its range of sterile ampoule products